NCT01501253View on ClinicalTrials.gov

CKD-828 S-Amlodipine Non-Responder Trial

PHASE3CompletedINTERVENTIONAL
Enrollment

187

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions
Hypertension
Interventions
DRUG

CKD-828 2.5/40mg

fixed dose combination of S-Amlodipine 2.5mg and Telmisartan 40mg

DRUG

CKD-828 2.5/80mg

Fixed dose combination of S-Amlodipine 2.5 and Telmisartan 80mg

DRUG

S-Amlodipine 2.5mg

S-Amlodipine 2.5mg monotherapy

Trial Locations (1)

Unknown

Seoul St. Mary's hospital, The catholic university of Korea, Seoul

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY

NCT01501253 - CKD-828 S-Amlodipine Non-Responder Trial | Biotech Hunter | Biotech Hunter